Anna Berkenblit

Insider Reports History

Location
Waltham, MA
Signature
/s/Charles Williams, Attorney-in-Fact for Anna Berkenblit
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Berkenblit:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP & CHIEF MEDICAL OFFICER Common Stock 113,935 $3,377,033 $29.64 30 Jun 2023 Direct
Surrozen, Inc./DE Director Option (right to buy) 1,333 14 May 2025 Direct
Surrozen, Inc./DE Director Option (right to buy) 1,333 05 Jun 2024 Direct

Insider Reports Filed by Anna Berkenblit

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRZN Surrozen, Inc./DE 14 May 2025 1 $0 4 Director 15 May 2025, 17:07
SRZN Surrozen, Inc./DE 05 Jun 2024 1 $0 4 Director 06 Jun 2024, 20:14
/report/000141588923010828-berkenblit-anna-2023-06-30 ImmunoGen, Inc. 30 Jun 2023 1 +$13,219 4 SVP & CHIEF MEDICAL OFFICER 05 Jul 2023, 17:56
SRZN Surrozen, Inc./DE 18 May 2023 1 $0 4 Director 22 May 2023, 09:34
/report/000141588923002106-berkenblit-anna-2023-02-03 ImmunoGen, Inc. 03 Feb 2023 3 $0 4 SVP & CHIEF MEDICAL OFFICER 07 Feb 2023, 16:22
/report/000141588923000108-berkenblit-anna-2022-12-30 ImmunoGen, Inc. 30 Dec 2022 1 +$1,709 4 SVP & CHIEF MEDICAL OFFICER 03 Jan 2023, 16:21
/report/000141588922007332-berkenblit-anna-2022-06-30 ImmunoGen, Inc. 30 Jun 2022 1 +$11,754 4 SVP & CHIEF MEDICAL OFFICER 05 Jul 2022, 16:31
SRZN Surrozen, Inc./DE 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 17:48
/report/000141588922012990-berkenblit-anna-2022-05-20 ImmunoGen, Inc. 20 May 2022 2 $0 4 SVP & CHIEF MEDICAL OFFICER 27 Dec 2022, 16:13
/report/000117911022000927-berkenblit-anna-2022-02-04 ImmunoGen, Inc. 04 Feb 2022 1 +$1,658,244 4 SVP & Chief Medical Officer 08 Feb 2022, 16:31
/report/000117911022000106-berkenblit-anna-2021-12-31 ImmunoGen, Inc. 31 Dec 2021 1 +$9,862 4 SVP & Chief Medical Officer 04 Jan 2022, 15:08
SRZN Surrozen, Inc./DE 11 Aug 2021 0 $0 3 Director 16 Aug 2021, 19:40
/report/000117911021007318-berkenblit-anna-2021-06-30 ImmunoGen, Inc. 30 Jun 2021 1 +$11,382 4 SVP & Chief Medical Officer 02 Jul 2021, 16:22
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .